Strategic merger creates one of the most comprehensive biostimulant and bionutritional platforms in North America
HGS BioScience, a leader in humic and fulvic acid-based products backed by Paine Schwartz Partners, announced today the acquisition of NutriAg Ltd., a Toronto-based innovator in bionutritional technologies.
This strategic merger brings together two complementary forces in agricultural innovation. HGS BioScience’s vertically integrated manufacturing and strong U.S. market presence now align with NutriAg’s advanced bionutritional portfolio, Canadian distribution network, and robust R&D capabilities.
“The biostimulant and bionutritional spaces are among the fastest-growing in agriculture — but they are fragmented and often confusing for retailers,” said Mike Steffeck, CEO of HGS BioScience. “By bringing HGS and NutriAg together, we are building one of the most robust platforms and pipelines in the market.”
The newly combined company will offer:
- Expanded Portfolio: A full suite of humic and fulvic acids, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
- Broader Market Access: Enhanced distribution across the U.S., Canada, and international markets.
- Deeper Innovation Pipeline: Proprietary technologies including NutriAg’s PolyAldoCarbosate® (PAC) platform and HGS’s HumiK ONE and GrowPlex brands.
NutriAg President and CEO Martin Bloomberg added, “Joining HGS is the next chapter for NutriAg. Our combined capabilities make us the partner of choice for both retailers and farmers.”
With this acquisition, HGS BioScience reinforces its position as a trusted, science-driven partner for agricultural retailers and growers—delivering proven solutions that drive yield, resilience, and profitability.